Michael S. Cuffe - Apr 24, 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
EVP and Chief Clinical Officer
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
Apr 24, 2023
Transactions value $
-$2,332,427
Form type
4
Date filed
4/26/2023, 04:54 PM
Previous filing
Feb 22, 2023
Next filing
May 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Options Exercise $3.24M +32K +111.24% $101.16 60.8K Apr 24, 2023 Direct F1
transaction HCA Common Stock Tax liability -$5.57M -19.5K -32.01% $286.25 41.3K Apr 24, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -32K -100% $0.00* 0 Apr 24, 2023 Common Stock 32K $101.16 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 2,363.3569 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
F2 The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.